Phase 4 Myasthenia Gravis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are over 18 years old, either male or female
• You have been diagnosed with a condition called generalized Myasthenia Gravis (gMG)
• You are already receiving a medication called ravulizumab as part of your treatment
• You have been taking oral corticosteroids (steroid tablets) at a dose equivalent to at least 7.5 mg of prednisone/prednisolone per day, continuously for at least 4 weeks before joining the trial
• If you are someone who could become pregnant, you must have a negative pregnancy test before the trial begins
• You are willing to read and sign a consent form agreeing to take part

Who may not be able to join:

• You are currently taking part in another clinical trial that involves a treatment or intervention
• You have a history of a condition called chronic hypoadrenalism (also known as Addison's disease), which affects your adrenal glands
• You are taking steroid tablets for any other health condition alongside your gMG
• You have recently received certain other biological medications used to treat gMG (such as efgartigimod, rozanolixizumab, inebilizumab, rituximab, or intravenous immunoglobulin) within a specific time period before enrolling (confirm with trial site)
• You are currently pregnant, breastfeeding, or planning to become pregnant during the course of the study

Important: Always verify eligibility with the trial site directly before applying.